Interleukin-1β-induced brain injury and neurobehavioral dysfunctions in juvenile rats can be attenuated by α-phenyl-n-tert-butyl-nitrone

Neuroscience

Volumn 168, Issue 1, 2010, Pages 240-252

  Fan, L W ^a   Tien, L T ^b   Zheng, B ^a   Pang, Y ^a   Rhodes, P G ^a   Cai, Z ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Antioxidant; Axonal and dendritic injury; Dopamine neuron; Interleukin 1 ; Neurobehavioral deficits

Indexed keywords

INTERLEUKIN 1BETA; MYELIN BASIC PROTEIN; N TERT BUTYL ALPHA PHENYLNITRONE; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE; AMINE OXIDE; LIPOPOLYSACCHARIDE; NEUROPROTECTIVE AGENT; PHENYL-N-TERT-BUTYLNITRONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; AVOIDANCE BEHAVIOR; AXONAL INJURY; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN VENTRICLE DILATATION; CELL LOSS; CELL MATURATION; CONTROLLED STUDY; DENDRITE; EARLY INTERVENTION; FEMALE; FORELIMB; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MAZE TEST; MYELINATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PASSIVE AVOIDANCE; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TASK PERFORMANCE; VENTRAL TEGMENTUM; VIBRISSA; WALKING; WHITE MATTER; ANIMAL; BRAIN; CEREBROVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; MICROGLIA; NERVE CELL; NERVE FIBER; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANIMALS; ANIMALS, NEWBORN; AVOIDANCE LEARNING; AXONS; BEHAVIOR, ANIMAL; BRAIN; CEREBROVASCULAR DISORDERS; CYCLIC N-OXIDES; FEMALE; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS; TYROSINE 3-MONOOXYGENASE;

EID: 77952891272     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.03.024     Document Type: Article

References (69)

1. Agmo A., Belzung C. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neuropharmacology 1998, 37:223-232.
2. Altman J., Sudarshan K. Postnatal development of locomotion in the laboratory rat. Anim Behav 1975, 23:896-920.
3. Altman J., Sudarshan K., Das G.D., McCormick N., Barnes D. The influence of nutrition on neural and behavioral development. 3. Development of some motor, particularly locomotor patterns during infancy. Dev Psychobiol 1971, 4:97-114.
4. Ba A., Seri B.V. Psychomotor functions in developing rats: ontogenetic approach to structure-function relationships. Neurosci Biobehav Rev 1995, 19:413-425.
5. Behl C., Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol Chem 2002, 383:521-536.
6. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J Neurosci 2005, 25:8000-8009.
7. Bilbo S.D., Rudy J.W., Watkins L.R., Maier S.F. A behavioural characterization of neonatal infection-facilitated memory impairment in adult rats. Behav Brain Res 2006, 169:39-47.
8. Cai Z., Lin S., Pang Y., Rhodes P.G. Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatr Res 2004, 56:377-384.
9. Cai Z., Pang Y., Lin S., Rhodes P.G. Differential roles of tumor necrosis factor-alpha and interleukin-1beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 2003, 975:37-47.
10. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992, 149:2736-2741.
11. Carbonell W.S., Murase S.I., Horwitz A.F., Wandell J.W. Infiltrative microgliosis: activation and long-distance migration of subependymal microglia following periventricular insults. J Neuroinflammation 2005, 2:5.
12. Colton C.A., Gilbert D.L. Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol 1993, 59:321-326.
13. Cunningham E.T., De Souza E.B. Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today 1993, 14:171-176.
14. Dammann O., Leviton A. Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev 2004, 79:1-15.
15. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997, 42:1-8.
16. De Ryck M., Van Reempts J., Duytschaever H., Van Deuren B., Clincke G. Neocortical localization of tactile/proprioceptive limb placing reactions in the rat. Brain Res 1992, 573:44-60.
17. Endoh H., Kato N., Fujii S., Suzuki Y., Sato S., Kayama T., Kotake Y., Yoshimura T. Spin trapping agent, phenyl N-tert-butylnitrone, reduces nitric oxide production in the rat brain during experimental meningitis. Free Radic Res 2001, 35. 583-391.
18. Fan L.W., Chen R.F., Mitchell H.J., Lin R.C., Simpson K.L., Rhodes P.G., Cai Z. α-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats. J Neurosci Res 2008, 86:3536-3547.
19. Fan L.W., Lin S., Pang Y., Rhodes P.G., Cai Z. Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat. Eur J Neurosci 2006, 24:341-350.
20. Fan L.W., Mirchell H.J., Rhodes P.G., Cai Z. Alpha-phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced neuronal injury in the neonatal rat brain. Neuroscience 2008, 151:737-744.
21. Fan L.W., Mirchell H.J., Tien L.T., Rhodes P.G., Cai Z. Interleukin-1β-induced brain injury in the neonatal rat can be ameliorated by α-phenyl-n-tert-butyl-nitrone. Exp Neurol 2009, 220:143-153.
22. Fan L.W., Mirchell H.J., Tien L.T., Zheng B., Pang Y., Rhodes P.G., Cai Z. α-phenyl-n-tert-butyl-nitrone reduces lipopolysaccharide-induced white matter injury in the neonatal rat brain. Dev Neurol 2008, 68:365-378.
23. Fan L.W., Tien L.T., Mitchell H.J., Rhodes P.G., Cai Z. α-Phenyl-n-tert-butyl-nitrone ameliorates hippocampal injury and improves learning and memory in juvenile rats following neonatal exposure to lipopolysaccharide. Eur J Neurosci 2008, 27:1475-1484.
24. Fan L.W., Pang Y., Lin S., Tien L.T., Ma T., Rhodes P.G., Cai Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res 2005, 82:71-82.
25. Floyd R.A., Hensley K., Bing G. Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics. J Neural Transm Suppl 2000, 60:387-414.
26. Floyd R.A., Hensley K., Forster M.J., Kelleher-Anderson J.A., Wood P.L. Nitrones as neuroprotectants and antiaging drugs. Ann N Y Acad Sci 2002, 959:321-329.
27. Floyd R.A., Hensley K. Nitrone inhibition of age-associated oxidative damage. Ann N Y Acad Sci 2000, 899:222-237.
28. Franco-Pons N., Torrente M., Colomina M.T., Vilella E. Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination 2007, 205-213, Toxicol Lett 169.
29. Frost S.B., Barbay S., Mumert M.L., Stowe A.M., Nudo R.J. An animal model of capsular infarct: endothelin-1 injections in the rat. Behav Brain Res 2006, 169:206-211.
30. Godoy M.C., Tarelli R., Ferrari C.C., Sarchi M.I., Pitossi F.J. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 2008, 131:1880-1894.
31. Green A.R., Ashwood T., Odergren T., Jackson D.M. Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059. Pharmacol Ther 2003, 100:195-214.
32. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371:75-84.
33. Goncalves L.F., Chaiworapongsa T., Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002, 8:3-13.
34. Hagberg H., Ichord R., Palmer C., Yager J.Y., Vannucci S.J. Animal models of developmental brain injury: relevance to human disease. Dev Neurosci 2002, 24:364-366.
35. Hagberg H., Peebles D., Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002, 8:30-38.
36. Hermans R.H., Hunter D.E., McGivern R.F., Cain C.D., Longo L.D. Behavioral sequelae in young rats of acute intermittent antenatal hypoxia. Neurotoxicol Teratol 1992, 14:119-129.
37. Holmin S., Mathiesen T. Intracerebral administration of interleukin-1β and induction of inflammation, apoptosis, and vasogenic edama. J Neurosurg 2000, 92:108-120.
38. Huleihel M., Golan H., Hallak M. Intrauterine infection/inflammation during pregnancy and offspring brain damages: possible mechanisms involved. Reprod Biol Endocrinol 2004, 2:7.
39. Kadhim H., Tabarki B., De Prez C., Sebire G. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy?. Acta Neuropathol (Berl) 2003, 105:209-216.
40. Kadhim H., Tabarki B., Verellen G., De Prez C., Rona A.M., Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278-1284.
41. Karl T., Pabst R., von Horsten S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 2003, 55:69-83.
42. Kerschensteiner M., Bareyre F.M., Buddeberg B.S., Merkler D., Stadelmann C., Bruck W., Misgeld T., Schwab M.E. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med 2004, 200:1027-1038.
43. Koprich J.B., Reske-Nielsen C., Mithal P., Isacson O. Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J Neuroinflammation 2008, 5:8.
44. Kotake Y., Sang H., Miyajima T., Wallis G.L. Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochim Biophys Acta 1998, 1448:77-84.
45. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
46. Landrigan P.J., Sonawane B., Butler R.N., Transande L., Callan R., Droller D. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect 2005, 113:1230-1233.
47. Lee J.H., Park J.W. The effect of alpha-phenyl-N-t-butylnitrone on ionizing radiation-induced apoptosis in U937 cells. Free Radic Res 2005, 39:1325-1333.
48. Lin S., Cox H.J., Rhodes P.G., Cai Z. Neuroprotection of alpha-phenyl-n-tert-butyl-nitrone on the neonatal white matter is associated with anti-inflammation. Neurosci Lett 2006, 405:52-56.
49. Lin S., Rhodes P.G., Lei M., Zheng F., Cai Z. alpha-Phenyl-n-butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain. Brain Res 2004, 1007:132-141.
50. Ling Z., Chang Q.A., Tong C.W., Leurgans S.E., Lipton J.W., Carvey P.M. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol 2004, 190:373-383.
51. Li P.A., He Q.P., Nakamura L., Csiszar K. Free radical spin trap alpha-phenyl-N-tert-butyl-nitron inhibits caspase-3 activation and reduces brain damage following a severe forebrain ischemic injury. Free Radic Biol Med 2001, 31:1191-1197.
52. Lynch A.M., Walsh C., Delaney A., Nolan Y., Campbell V.A., Lynch M.A. Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10-a role for IL-1beta?. J Neurochem 2004, 88:635-646.
53. Maciag D., Simpson K.L., Coppinger D., Lu Y., Wang Y., Lin R.C., Paul I.A. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006, 31:47-57.
54. Osterhout D.J., Marin-Husstege M., Abano P., Casaccia-Bonnefil P. Molecular mechanisms of enhanced susceptibility to apoptosis in differentiating oligodendrocytes. J Neurosci Res 2002, 69:24-29.
55. Pang Y., Cai Z., Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res 2003, 140:205-214.
56. Parnet P., Kelley K.W., Bluthe R.M., Dantzer R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J Neuroimmunol 2002, 125:5-14.
57. Prakash N., Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell Mol Life Sci 2006, 63:187-206.
58. Rezaie P., Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002, 22:106-132.
59. Sang H., Wallis G.L., Stewart C.A., Kotake Y. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch Biochem Biophys 1999, 363:341-348.
60. Schallert T., Woodlee M.T. Motor systems: orienting and placing. The behaviour of the laboratory rat: a handbook with tests 2005, 129-140. Oxford University Press, New York. I.Q. Whishaw, B. Kolb (Eds.).
61. Schmitt U., Luddens H., Hiemke C. Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats. J Neural Transm 2002, 109:871-880.
62. Shen Y., Isaacson R.L., Smotherman W.P. The behavioral and anatomical effects of prenatal umbilical cord clamping in the rat and their alteration by the prior maternal administration of nimodipine. Restor Neurol Neurosci 1991, 3:11-22.
63. Spolidorio P.C., Echeverry M.B., Iyomasa M., Guimaraes F.S., Del Bel E.A. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus. Psychopharmacology (Berl) 2007, 195:183-192.
64. Thorburne S.K., Juurlink B.H. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 1996, 67:1014-1022.
65. Thornton P., Pinteaux E., Gibson R.M., Allan S.M., Rothwell N.J. Interleukin-1-induced neurotoxicity is mediated by glia and requires caspaseactivation and free radical release. J Neurochem 2006, 98:258-266.
66. Volpe J.J. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003, 112:176-180.
67. Yoon B.H., Jun J.K., Romero R., Park K.H., Gomez R., Choi J.H., Kim I.O. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997, 177:19-26.
68. Yoon B.H., Romero R., Kim C.J., Koo J.N., Choe G., Syn H.C., Chi J.G. High expression of tumor necrosis factor-α and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997, 177:406-411.
69. Yoon B.H., Romero R., Yang S.H., Jun J.K., Kim I.O., Choi J.H., Syn H.C. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174:1433-1440.